Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kazuaki Taguchi

Showing results (41-50 of 197) with videos related to

Pageof 20
Sort By:
Toxicology and Applied Pharmacology|November 13, 2023
Elucidating the binding properties of methemoglobin in red blood cell to cyanide, hydrosulfide, and azide ions using artificial red blood cellYuto Suzuki, Yo Arakida, Hiromi Sakai, et al.
Biological & Pharmaceutical Bulletin|August 2, 2019
Age-Associated Theophylline Metabolic Activity Corresponds to the Ratio of 1,3-Dimethyluric Acid to Theophylline in MiceYuko Kuroda, Kazuaki Taguchi, Yuki Enoki, et al.
Chemical & Pharmaceutical Bulletin|April 3, 2018
Preparation and in Vitro Analysis of Human Serum Albumin Nanoparticles Loaded with Anthracycline DerivativesKotaro Kimura, Keishi Yamasaki, Hideaki Nakamura, et al.
Biological & Pharmaceutical Bulletin|September 4, 2020
Pharmacokinetic Properties of Orally Administered 4'-Cyano-2'-deoxyguanosine, a Novel Nucleoside Analog Inhibitor of the Hepatitis B Virus, in Viral Liver Injury Model RatsMai Hashimoto, Kazuaki Taguchi, Shuhei Imoto, et al.
Biological & Pharmaceutical Bulletin|November 6, 2019
Evaluation of the Expression Time of Ganciclovir-Induced Adverse Events Using JADER and FAERSGo Ando, Kazuaki Taguchi, Yuki Enoki, et al.
Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy|January 2, 2021
Pharmacokinetics of 4'-cyano-2'-deoxyguanosine, a novel nucleoside analog inhibitor of the resistant hepatitis B virus, in a rat model of chronic kidney diseaseMai Hashimoto, Kazuaki Taguchi, Shuhei Imoto, et al.
The Journal of Antimicrobial Chemotherapy|December 12, 2024
Simulated achievement rate of β-lactams/nacubactam treatment in humans using instantaneous MIC-based PK/PD analysisYuki Igarashi, Kazuaki Taguchi, Yuki Enoki, et al.
Journal of Colloid and Interface Science|August 5, 2023
Polysarcosine-Coated liposomes attenuating immune response induction and prolonging blood circulationMingxin Hu, Kazuaki Taguchi, Kazuaki Matsumoto, et al.
ACS Omega|July 3, 2023
Pharmaceutical Integrity of Lyophilized Methemoglobin-Albumin Clusters after ReconstitutionYuto Suzuki, Kazuaki Taguchi, Wataru Okamoto, et al.
FEBS Letters|August 9, 2024
T-cell immunosuppression in sepsis is augmented by sciatic denervation-induced skeletal muscle atrophySumika Osa, Yuki Enoki, Daisuke Takahashi, et al.
Pageof 20

Showing results (41-50 of 197) with videos related to

Sort By:
Pageof 20
Toxicology and Applied Pharmacology|November 13, 2023
Elucidating the binding properties of methemoglobin in red blood cell to cyanide, hydrosulfide, and azide ions using artificial red blood cellYuto Suzuki, Yo Arakida, Hiromi Sakai, et al.
Biological & Pharmaceutical Bulletin|August 2, 2019
Age-Associated Theophylline Metabolic Activity Corresponds to the Ratio of 1,3-Dimethyluric Acid to Theophylline in MiceYuko Kuroda, Kazuaki Taguchi, Yuki Enoki, et al.
Chemical & Pharmaceutical Bulletin|April 3, 2018
Preparation and in Vitro Analysis of Human Serum Albumin Nanoparticles Loaded with Anthracycline DerivativesKotaro Kimura, Keishi Yamasaki, Hideaki Nakamura, et al.
Biological & Pharmaceutical Bulletin|September 4, 2020
Pharmacokinetic Properties of Orally Administered 4'-Cyano-2'-deoxyguanosine, a Novel Nucleoside Analog Inhibitor of the Hepatitis B Virus, in Viral Liver Injury Model RatsMai Hashimoto, Kazuaki Taguchi, Shuhei Imoto, et al.
Biological & Pharmaceutical Bulletin|November 6, 2019
Evaluation of the Expression Time of Ganciclovir-Induced Adverse Events Using JADER and FAERSGo Ando, Kazuaki Taguchi, Yuki Enoki, et al.
Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy|January 2, 2021
Pharmacokinetics of 4'-cyano-2'-deoxyguanosine, a novel nucleoside analog inhibitor of the resistant hepatitis B virus, in a rat model of chronic kidney diseaseMai Hashimoto, Kazuaki Taguchi, Shuhei Imoto, et al.
The Journal of Antimicrobial Chemotherapy|December 12, 2024
Simulated achievement rate of β-lactams/nacubactam treatment in humans using instantaneous MIC-based PK/PD analysisYuki Igarashi, Kazuaki Taguchi, Yuki Enoki, et al.
Journal of Colloid and Interface Science|August 5, 2023
Polysarcosine-Coated liposomes attenuating immune response induction and prolonging blood circulationMingxin Hu, Kazuaki Taguchi, Kazuaki Matsumoto, et al.
ACS Omega|July 3, 2023
Pharmaceutical Integrity of Lyophilized Methemoglobin-Albumin Clusters after ReconstitutionYuto Suzuki, Kazuaki Taguchi, Wataru Okamoto, et al.
FEBS Letters|August 9, 2024
T-cell immunosuppression in sepsis is augmented by sciatic denervation-induced skeletal muscle atrophySumika Osa, Yuki Enoki, Daisuke Takahashi, et al.
Pageof 20